AKT1 and melanoma: Because previous studies have reported that Akt and ERK signaling pathways regulate PD‐L1 expression in melanoma cells (Atefi et al., 2014), we examined the effect of chemotherapeutic drugs on the activity of these two signaling pathways in stromal cells to identify the molecular events associated with PD‐L1 induction.